EUVIMEDEUVIMED entdecken
Crossref

The longitudinal microbial and metabolic landscape of infant cystic fibrosis: the gut–lung axis

Katherine B Frayman iD, Matthew Macowan iD, Jose Caparros-Martin, Sarath C Ranganathan, Benjamin J Marsland, SYNERGY CF

European Respiratory Journal · 2024-05 · 63 (5) · 2302290

DOI: 10.1183/13993003.02290-2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 14.03.2024. Verfasst von Katherine B Frayman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Diseases Group, Murdoch Children's Research Institute, Melbourne, Australia katherine.frayman@rch.org.au. Hauptthemen laut MEDLINE: Cystic Fibrosis, Bronchoalveolar Lavage Fluid, Feces, RNA, Ribosomal, 16S. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aim In cystic fibrosis, gastrointestinal dysfunction and lower airway infection occur early and are independently associated with poorer outcomes in childhood. This study aimed to define the relationship between the microbiota at each niche during the first 2 years of life, its association with growth and airway inflammation, and explanatory features in the metabolome. Materials and methods 67 bronchoalveolar lavage fluid (BALF), 62 plasma and 105 stool samples were collected from 39 infants with cystic fibrosis between 0 and 24 months who were treated with prophylactic antibiotics. 16S rRNA amplicon and shotgun metagenomic sequencing were performed on BALF and stool samples, respectively; metabolomic analyses were performed on all sample types. Sequencing data from healthy age-matched infants were used as controls.

Results

Bacterial diversity increased over the first 2 years in both BALF and stool, and microbial maturation was delayed in comparison to healthy controls from the RESONANCE cohort. Correlations between their respective abundance in both sites suggest stool may serve as a noninvasive alternative for detecting BALF Pseudomonas and Veillonella . Multisite metabolomic analyses revealed age- and growth-related changes, associations with neutrophilic airway inflammation, and a set of core systemic metabolites. BALF Pseudomonas abundance was correlated with altered stool microbiome composition and systemic metabolite alterations, highlighting a complex gut–plasma–lung interplay and new targets with therapeutic potential.

Conclusion

Exploration of the gut–lung microbiome and metabolome reveals diverse multisite interactions in cystic fibrosis that emerge in early life. Gut–lung metabolomic links with airway inflammation and Pseudomonas abundance warrant further investigation for clinical utility, particularly in non-expectorating patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisBronchoalveolar Lavage FluidFecesRNA, Ribosomal, 16SLungGastrointestinal MicrobiomeHumansInfantMaleFemaleInfant, NewbornLongitudinal StudiesCase-Control StudiesMetabolomeMetabolomicsAnti-Bacterial AgentsChild, Preschool

Substanzen

RNA, Ribosomal, 16SAnti-Bacterial Agents

Autor:innen und Institutionen

  • Respiratory Diseases Group, Murdoch Children's Research Institute, Melbourne, Australia katherine.frayman@rch.org.au.
  • Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Australia.
  • K.B. Frayman and M. Macowan are joint first authors.
  • Department of Immunology and Pathology, Monash University, Melbourne, Australia.
  • Wal-yan Respiratory Research Centre, Telethon Kids Institute, Perth, Australia.
  • Respiratory Diseases Group, Murdoch Children's Research Institute, Melbourne, Australia.

ORCID-Profile: Katherine B Frayman, Matthew Macowan

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Frayman, K. B., Macowan, M., Caparros-Martin, J., Ranganathan, S. C., Marsland, B. J., & SYNERGY CF (2024). The longitudinal microbial and metabolic landscape of infant cystic fibrosis: the gut–lung axis. European Respiratory Journal, 63(5), 2302290. https://doi.org/10.1183/13993003.02290-2023

Vancouver

Frayman KB, Macowan M, Caparros-Martin J, Ranganathan SC, Marsland BJ, SYNERGY CF. The longitudinal microbial and metabolic landscape of infant cystic fibrosis: the gut–lung axis. European Respiratory Journal. 2024;63(5):2302290. doi:10.1183/13993003.02290-2023

BibTeX
@article{Frayman2024,
  author = {Frayman, Katherine B and Macowan, Matthew and Caparros-Martin, Jose and Ranganathan, Sarath C and Marsland, Benjamin J and SYNERGY CF, SYNERGY CF},
  title = {The longitudinal microbial and metabolic landscape of infant cystic fibrosis: the gut–lung axis},
  journal = {European Respiratory Journal},
  year = {2024},
  volume = {63},
  number = {5},
  pages = {2302290},
  doi = {10.1183/13993003.02290-2023}
}
Kostenlos starten →